detected in HCC histology: 55% TERT promoter mutations, 31% TP53, 31% CTNNB1 and 1% PIK3CA mutations, respectively (a comparison of all oncogenic mutations analyzed is provided in supplementary Table 4). This evidence concerns the gene TERT and hepatocellular carcinoma.